NOD-like proteins (NLR) are a specialized group of intracellular receptors, which constitute an essential component of the host innate immune system. They were discovered more than a decade ago, but research on this particular class of microbial detectors is still ongoing to allow for a better understanding of the mechanisms, recognition of microorganisms, transmission of signals, and carrying out the activation of inflammatory signaling pathways. In this review, we discuss the construction of NOD1 and NOD2 receptors, their functions, and significance in the pathogenesis of inflammatory diseases in humans.
INTRODUCTION
Response to impulses from the environment is possible through the presence of the PRR (pattern recognition receptors), which selectively recognize specific conserved structures known as pathogen associated molecular patterns (PAMPs) (Takeuchi et al., 2010) , as well as DAMPs (damage-associated molecular pattern molecules) that are released by stressed cells undergoing necrosis and can initiate and perpetuate immune response in the noninfectious inflammatory response (Foell et al., 2007) . These receptors constitute an integral component of the non-specific and specific immune system. PRR can be associated with the cell membrane, the endosome membrane, or they can be found in the cytoplasm. PRR include Toll-like receptors (TLR), lectin receptors C-type (CLR), RIG-I-like receptors (RLR), and NOD-like receptors (NLR). All of these play important roles in the response to microbial infection Takeuchi et al., 2010; Kvarnhammar et al., 2012) . The structure of NLR proteins is unique and contains several domains, which are highly conserved Martinon et al., 2005) . Their common feature is the presence of a centrally located, conservative nucleotide-binding oligomerization domain (NBD), responsible for oligomerization of the receptor, the C-terminal domain of leucine rich repeats (LRR), and the N-terminal effector domain (Fig. 1) . The NLR receptor family contains 23 members, which are divided into five subfamilies, mainly due to the type of the N-terminal effector domain (Tig et al., 2008) .
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NOD SUBFAMILY
The NOD (nucleotide-binding oligomerization domain-containing proteins) subfamily includes five proteins: NOD1, NOD2, NLRC3, NLRC4, NLRC5. NOD1, and NOD2 (gene products CARD4 and CARD15, respectively). These are large cytoplasmic proteins, which are best known proteins in this group. The NOD1 receptor consists of 953 amino acids, its molecular weight is 97 kDa, while the molecular weight of NOD2 is 110 kD and it contains 1040 amino acids (Inohara et al., 1999; Kufer et al., 2008) . The NOD1 N-terminal effector domain contains a CARD (caspase-recruting domain) domain, while NOD2 contains two CARD domains. CARD domain interacts with caspases involved in apoptosis and inflammation, including caspase 1. It was also revealed that the CARD-mediated caspase-independent interaction ) is responsible for binding of signaling proteins and intracellular signal transduction. The central NBD domain is responsible for ATP-dependent regulation by oligomerization of the receptor, while the C-terminal domain for detection of ligands (microbial components) (Benko et al., 2008; Magalhaes et al., 2011) . The NOD subfamily also contains the NLRC4 receptor, known as IPAF. It interacts with procaspase-1 through the CARD domain, and could be involved in the activation of caspase-1 in response to pro-inflammatory and apoptotic stimuli. In spite of similar construction to NOD1 and NOD2, this protein is not involved in the activation of the transcription nuclear factor kappaB (NF-κB) (Poyet et al., 2001) . This group also contains the NOD3 receptor, which inhibits the TLR-dependent activation of the NF-κB transcription factor (Schneider et al., 2012) .
Tissue localization of human NOD1 and NOD2 receptors
NOD1 receptor is common in many tissues, however the presence of NOD2 is confined only to leukocytes and epithelial cells Uehara et al., 2007; Correa et al., 2012) . The mature cells of peripheral blood demonstrated the highest level of NOD2 expression in monocytes, granulocytes, and dendritic cells (Gutierrez et al., 2002) , as well as low NOD2 expression in T lymphocytes . NOD1 and NOD2 expression was also demonstrated in peripheral B-type blood cells, while in tonsillar B cells only the expression of NOD1 was discovered (O'Neill et al., 2011) .
NOD1 and NOD2 ligands
NOD1 and NOD2 were shown to recognize fragments of the bacterial cell wall component called peptidoglycan (PG). PG is a glycol heteropolymer composed of a sugar chain consisting of glycan chains of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc). These molecules are linked with β-1,4-glycosidic bonds. An integral part of PG are protein components, which contain unique amino acids such as the L-alanine (L-Ala), D-glutamic acid (D-Glu), meso-diaminopimelic acid (mDAP), L-lysine (L-Lys), and D-alanine (D-Ala) (Karaś et al., 2006; Carneiro et al., 2008; Bugla-Płoskońska et al., 2008 ). An important differentiation feature is an amino acid located at the third position of the peptide chain. In Gram-positive bacteria it is the L-lysine (Lys-PG), while in the majority of Gram-negative bacteria it is the meso-diaminopimelic acid (DAP-PG) (Szilvia et al., 2008) . The NOD1 receptors recognize the PG moieties containing γ-D-glutamyl-
, particularly present in Gram-negative bacteria and some Gram-positive bacteria, such as Listeria monocytogenes and Bacillus spp. A minimal structure recognized by NOD1 is dipeptide iEDAP Carneiro et al., 2008; Correa et al., 2012) . The NOD2 receptor detects and binds directly to muramyl dipeptide (MDP) (which consists of MurNAc, L-alanine, and D-glutamic acid) and Muramyl-TriLys (Szilvia et al., 2008) . These structures are present both in Gram-positive and Gramnegative bacteria (Fig. 2) .
On the basis of the cytosolic localization, NOD1 and NOD2 receptors may respond primarily to: a/ bacteria, which evade being detected by TLR, b/ bacterial components delivered to the cytosol by the secretion systems or by created pores, c/ bacterial products, which are delivered by phagocytosis or pinocytosis. NOD1 and NOD2 receptors appear to recognize both invasive and non-invasive forms of the bacteria. In the latter case, stimulation of intracellular reconnaissance system of the NOD receptors is carried out by a functional bacterial system type III secretion (T3SS or TTSS) and IV (T4SS or TFSS) functioning in Gram-negative bacteria. Proteins involved in these processes are encoded in the genome of bacteria in regions called pathogenicity sites, which for T3SS are referred to as SPI-2, and cag PAI for the T4SS type (Wong et al., 2004) . The T3SS type allows to "inject" bacterial proteins directly into the cytoplasm of the host cell by passing the periplasmic space of external environment (Galan et al., 2006 2005; Kusters et al., 2006) . The CagA (cytotoxin-associated protein A) is a large (120-145 kDa) and highly immunogenic protein, encoded by the cagA gene, located within the pathogenicity site cag PAI. After an entry into host cells CagA is phosphorylated by two types of interacting cellular kinases: SFKs kinase (src-family protein tyrosine kinases) and Abl kinase (abelson tyrosine kinase). The CagA phosphorylation level determines the way of interaction with a variety of proteins in eukaryotic cell and induction of signaling pathways. Unchanged pathogenicity sites cag are required for proper NOD1signaling.
H. pylori strains that do not have cag sites have reduced activation level of NF-κB (Viala et al., 2004) . Research of Boughan et al. (2006) and Viala et al. (2004) have proven the role of NOD1 in identifying these bacteria. They have revealed that NOD1-deficient mice exhibit an increased susceptibility to H. pylori infection, which was associated with disorders in production of an antimicrobial peptide: β-defensin. In vitro studies have shown that physical contact between host cells and living bacteria is not necessary. The NOD1 agonists can get into the cell via endocytosis and phagocytosis (dead bacteria) (Opitz et al., 2004) . Bacterial secretion systems allow to create pores through pathogens, what enables them to leave the phagosome after phagocytosis and to transport bacterial products. For instance, listeriolysin O -a toxin creating pores, is an important virulence factor of Listeria monocytogenes. Lack of listeriolysin O completely excludes pathogenicity. It allows to deliver PG into the host cells and enables its recognition by NOD1 and NOD2 (Opitz et al., 2006; Lenz et al., 2006) .
Signal transmission through NOD1 and NOD2
The main function of PRR includes the activation of inflammatory signaling pathways. In some aspects, NLR signaling is very similar to the extracellular receptor TLR stimulation. After the TLR membrane recognizes relevant PAMPs, the adapter proteins such as MyD88 (myeloid differentation primary response protein 88), TIRAP (TIR domain-containing adapter protein), and TRIF (TIR-domain-containing adapter-inducing interferon-β) become involved, and they lead to activate signaling pathways of mitogen-activated kinases (MAPK) and nuclear transcription factor (NF-κB), resulting in the induction of proinflammatory mediators and agents such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and IL-1β (Kawai & Akira 2006) . Similarly, stimulation of intracellular NOD1 and NOD2 activates signaling pathways, whose main targets are: NF-κB, MAPK, and caspase-1. As a consequence of this activation, the corresponding genes transcription and inflammatory mediators production starts. Proper activation of the signaling pathway of the NOD1 and NOD2 receptor is tightly regulated by post-translational modifications such as phosphorylation and ubiquitination (Jiang et al.,2011; Tigno-Aranjuez et al., 2012) . Recognition of the agonists by NOD1 and NOD2 initiate their own oligomerization and exposure of the CARD domain for recruitment and activation of the RIP2 (Receptor-interacting protein 2) adapter protein, also known as RICK (RIP-like interacting clarp kinase) or CARDIAK (CARD-containing ice -associated kinase) Nembrini et al., 2009) . The RIP protein family consists of seven members characterized by the presence of serine-threonine properties domain. The C-terminal RIP2 contains the CARD domain, similar to the CARD domain of the NOD1 and NOD2 receptor. Transmission of signals from receptors to RIP2 is possible through CARD-CARD interactions. The RIP2 protein is a strategic moment for the proper functioning of the signaling pathway . Active RIP2 kinase can directly lead to ubiquitination of NEMO (NF-κB essential modulator) and thus the activation of the IKK complex (IκB kinase). Active IKK complex phosphorylates the NF-κB inhibitor (IκBα-inhibitor of kappaB). Phosphorylated IκBα is degraded, and release free NF-κB occurs followed by its translocation into the nucleus. In the nucleus, NF-κB inducts the expression of over 200 genes including genes encoding proinflammatory cytokines, growth factors, factors responsible for stimulation of immune cells, and others (Burns et al., 2004; Rahighi et al., 2009; Jiang et al., 2011) . RIP2 also activates TAK1 kinase (transforming growth factor β-activated kinase1), which can affect the IKK complex, and activate one of the three main families of MAP kinases: p38, JNK, and ERK. As a result of the pathway activation involving MAPK, a release of the AP1 transcription factor responsible for control of cell proliferation, cell differentiation, and apoptosis occurs (Karin et al., 1995; Kobayashi et al., 2005) . NOD1 and NOD2 also activate other signaling pathways of not completely understood mechanisms, although the adapter proteins active in these pathways are well documented in TLR3, TLR7, TLR8, and TLR9 signaling pathways. Upon binding the bacterial ligand, NOD1 or NOD2 induce ownoligomerization and recruitment of RIP2, which binds TRAF3 (tumor necrosis factor receptor-associated factor 3). This protein activates the TBK1 kinase (TANK binding kinase 1) and IKKε (kinase inhibitor of nuclear factor kappaB), which phosphorylates and activates regulatory factors IRF3 and IRF7 (interferon regulatory factor 3, 7). Activated IRF3 and IRF7 form homodimers and/or heterodimers, they pass into the nucleus, where they bind with the molecules of ISRE (IFN-stimulated response elements) inducing the IFN gene expression of type I (Takeuchi & Akira 2009; McCartney et al., 2009; Correa et al., 2012) . Type I interferons activate dendritic cells and NK cells. They are also responsible for carrying out the effector functions of B and T lymphocytes thus linking the innate and adaptive immune responses. The type I IFN releases subsequent mediators, which directly interact with viruses and inhibit their proliferation (Theofilopoulos et al., 2005) (Fig. 3) .
Antiviral RIP2-independent pathway
For nearly 10 years, NOD2 have been connected with the functioning of RIP2 in mediating the induction of NF-κB and pro-inflammatory responses induced by PG. Recent studies have shown that NOD2 has a wider biological activity including antiviral response through alternative way. It was demonstrated in vitro that after stimulation of NOD2 with viral ssRNA (single-stranded RNA) an activation of IRF3 occurs. This observation was confirmed in vivo in patients infected with respiratory syncytial virus (RSV) (Sabbah et al., 2009) . In mouse models, Sabbah et al. (2009) revealed that NOD2 (but not NOD1) binds with a virus ssRNA, then this complex translocates towards the mitochondria and activates the mitochondrial antiviral signaling protein MAVS (mitochondrial antiviral-signaling), also known as VISA (virus-induced signaling adapter), IPS-1 (interferon-β promoter stimulator 1), or CARDIF (CARD adaptor inducting IFNB). Complex MAVS-NOD2 is created through NBD and LRR domains. The NOD2 CARD domain is not essential for the interaction with MAVS. Two important functional domains, CARD and TM, are distinguished in the MAVS protein structure. The C-terminal transmembrane domain (TM) links with the outer mitochondrial membrane, while the N-terminal domain CARD interacts with the CARD of cytoplasmic RNA helicases that recognize viral infections such as RIG-I (retinoic acid inducible gene I) and MDA5 (melanoma differentiation-associated gene 5) (Yoneyama et al., 2004; Kawai et al., 2005; Fritz et al., 2006) . As a consequence of this interaction, MAVS binds to IKKα/β kinases (activating NF-κB). The interaction of TBK1 and IKKε results in the activation of IRF3. Coordinated activation of signaling pathways of NF-κB and IRF3 leads to the creation of a multiprotein reinforcement complex that accelerates the expression of interferon-β (IFN-β) and hence the antiviral resistance (Sun et al., 2006; Qi et al., 2007; Lecat et al., 2010; Ting et al., 2010) . It has been shown that MAVS also connects directly to TRAF3 but its exact role in this pathway and the IKK complex activation is not well studied (Correa et al., 2012) . However, many viruses have developed strategies that interfere and derange these innate signaling events thus inhibiting the IFN-β production. In this mechanism, an activated serine protease cleaves the TM domain from the MAVS molecule via proteolytic degradation, thereby disconnecting the MAVS protein from the mitochondria and causing its dysfunction (Correa et al., 2012) (Fig. 4) .
Other functions of NOD1 and NOD2 in the processes of pathogens elimination
The NOD1 and NOD2 receptors are involved in the process of autophagy (autophagocytosis), what has been proven in plants and animals including mammals. (Travassos et al., 2010) . This process involving NOD1 and NOD2 is based on their cooperation with the AT-G16L1 (autophagy related 16-like 1) protein, a component of the protein complex acting as a regulator of this mechanism (Homer et al., 2010) . This mechanism is independent from the adapter protein RIP2 and transcription factor NF-κB (Travassos et al., 2010) . In ATG16L deficient cells, both creation of autophagosomes and degradation of long-lived proteins are seriously impaired (Saitoh et al., 2008) . The NOD and ATG16L receptors are essential for induction of autophagy in intestinal epithelial cells after pathogen stimulation (Ravikumar et al., 2004) . During the bacterial infection both associated proteins move toward the cell membrane and participate in the formation of autophagosome follicles around the bacteria (Wickner, 2002) . Autophagosome and lysosome fusion leads to degradation of bacteria followed by the presentation of bacterial antigenic determinants to T cells, in the context of the MHC class II antigens. The role of NOD2 in the induction of autophagy is confirmed in studies revealing that NOD2 mutation prevents the induction of autophagy (Shaw et al., 2011) . The most recent reports indicate that the control of signal transduction pathways through NOD1 and NOD2 is also held via CARD and ubiquitin (Ub) (Ver Heul et al., 2013) .
A small hydrophobic surface of CARD that binds Ub was identified by nuclear magnetic resonance spectroscopy (NMR) and structure-guided mutagenesis. In vivo studies with the CARD domain mutated in Ub binding site have demonstrated the inability of Ub connection, while retaining the ability to bind RIP2 and ATG16L. Such mutation leads to a significant hyperactivity of the NOD1 and NOD2 receptors after ligand-stimulation. These data suggest that Ub-binding provides a negativefeedback loop of the NOD-dependent activation of RIP2.
NOD1 and NOD2 are also involved in the mechanism of reactive oxygen species formation (ROS) -an essential part of the antimicrobial response (Tan et al., 2012) . ROS directly activates the DUOX2 protein (dual oxidase 2 protein). DUOX2 is a protein subunit, one of the isoforms of the NADPH oxidase (reduced form of nicotinamide adenine dinucleotide phosphate oxidase), a key enzyme involved in the first line of defense against pathogens. Hydrogen peroxide, which has antibacterial properties, is released in phagocytes via the DUOX2 protein during an infection (Lipinski et al., 2009; Kersse et al., 2011) . A higher expression level of DOUX2 was proven in inflamed cells when compared to the normal tissue (Ha et al., 2005; Lipinski et al., 2009) .
Biological response to NOD1 and NOD2 signaling
The consequence of NF-κB and MAPK activation mediated by NOD1 and NOD2 is triggering of transcription and production of inflammatory mediators. Inflammatory cytokines IL-1β, IL-6, TNFα, IL-8, IL-18, IL-12p40, IL-12p70 (Carneiro et al., 2008; Kersse et al., 2011) , oxide nitrogen (Tötemeyer et al., 2006; Carneiro et al., 2008) , and cell adhesion molecules (Carneiro et al., 2008) are produced in the dendritic cells, lymphocytes, monocytes and macrophages. The epithelial cells, through the activation of the NOD1 and NOD2 receptors, produce pro-inflammatory mediators such as TNF, IL-6, IL-8, MIP2 (macrophage inflammatory protein 2), and antimicrobial peptides (e.g. β-defensin2) (Carneiro et al., 2008; Kersse et al., 2011) , what significantly expedites fighting pathogens. NOD1 stimulation in epithelial and mesothelial cells induces chemokine production and recruitment of immune effector cells, including neutrophils in vivo . In vitro studies have revealed that overexpression of NOD1 and NOD2 may induce apoptosis . These pathways are not completely elucidated, although it has been shown that in the case of NOD1 the process involves caspase-8 and caspase-9 and requires the RIP2 protein (Windheim et al., 2007) .
Moreover, obtained results suggest that NOD1 and NOD2 stimulation induces an increased expression of a major histocompatibility complex class II (MHC II) proteins on the surface of antigen presenting cells (macrophages, dendritic cells, B lymphocytes) (Homer et al., 2010; Travaassos et al., 2010; Shaw et al., 2011) , what indicates that these receptors are essential in coordinating the adaptive immune response (Fritz et al., 2007) .
Another factor indicating the role of NOD2 in this type of response is an observation that NOD2 agonist (muramyl dipeptide) may function as an effective adjuvant for antigen-specific T-cell response and antibody production by B lymphocytes (Sugimoto et al., 1978) .
NOD1 and NOD2 signaling regulation
It has been shown that NOD1 and NOD2 interact with different intracellular molecules that may positively or negatively regulate their signaling pathway ( Table  1 ). The most significant inhibitory effect on NOD2 is caused by the Erbin protein. This protein is combined with intact CARD and LRR NOD2 domains inhibiting the receptor's function. In case of the NOD2 LRR domain's damage, the function of Erbin is not observed . Yamamoto-Furusho et al. (2006) , using siRNA against CENTβ1 (centaurin β1), confirmed the theory that CENTβ1 overexpression inhibits the activation of NOD2-dependent NF-κB, which places them in a group of the NOD1 and NOD2 inhibitory proteins. Another inhibitory protein is the AAMP (angio-associated migratory cell protein), because of the involvement of this protein in angiogenesis. AAMP combines with the CARD domain of the NOD2 receptor preventing the formation of a NOD2-RIP2 complex (Bielig et al., 2009) . GTPase Rac1 (ras-related C3 botulinum toxin substrate 1 GTPase) negatively affects the NOD2-dependent release of IL-8 (Eitel et al., 2008) . Another negative regulator of NOD2 was described by Zurek et al. (2012) RIG-I (retinoic acid-inducible gene 1). This cytoplasmic receptor protein, which recognizes viruses through its CARD domain, can bind to different regions of the NOD2, inhibiting the release of NF-κB (Morosky et al., 2011) . Another identified inhibitor is the JNKBP1 (c-Jun N-terminal kinase-binding protein) cytoskeleton protein, characterized by the presence of the WD-40 domain, via which it combines with the NOD2 receptor following the MDP activation. JNKBP1-NOD2 complex interferes with the oligomerization of NOD2, prevents the activation of NF-κB, secretion of IL-8, and antibacterial response (Lecat et al., 2012) . The recently identified inhibitor TRIM27 (T-cell receptor molecule interacting 27), which interacts with NOD2 via the NBD domain, inhibits the pro-inflammatory response. It was noted that the increased expression of TRIM27 occurs in patients with Crohn's disease (Zurek et al., 2012) . A negative impact on the mechanisms of innate immunity also appears in the TRAF4 protein (TNF receptor-associated factor 4), as a sole representative of the TRAF's family. By binding to NOD2, it inhibits the activation of NF-κB (Marinis et al., 2012) .
The proteins, whose mechanism of action is poorly understood, stimulating the function of NOD2 have also been identified (Table 1) . It was stated that GRIM19 (Barnich et al., 2005) , CARD9 , and Vimentin (Stevens et al., 2012) are required for the activation of NF-κB through NOD2.
MUTATIONS IN THE NOD1 AND NOD2 GENES AS A CAUSE OF DISEASES IN HUMANS
The physiological role of various NLR is to defend the host against bacterial infections. More often however, the role of these receptors is attributed to maintaining organ homeostasis. This is substantiated by the fact that many non-inflammatory disease processes originate in NLR defective signaling, caused by mutations within its genes. Dysregulation of NLR function has been described in a variety of disorders, including chronic inflammations, autoimmunity and cancer predisposition (Carneiro et al., 2008; Davis et al., 2011) . It was revealed that disruption of the NOD1 and NOD2 function caused by its gene mutations may contribute to the pathogenesis of inflammatory bowel diseases (Boughan et al., 2006; Uehara et al., 2007; Zilbauer et al., 2007) . Still little is known about the mechanism of regulation in different diseases. So far, mutations and polymorphisms within the NOD1 and NOD2 receptors have been identified, however, the importance of the level of ubiquitination and phosphorylation remains to be established. It has only been proven that mutations in the NOD2 receptor and A20 (ubiquitin modifying enzyme) associated with Crohn's disease can affect the condition of ubiquitination. An increased level of RIP2 ubiquitination was observed in the A20 null cells. After activating NOD2, NEMO also undergoes ubiquitination and thus activates IKK. It is interesting that in Crohn's disease, where mutations of NOD2 are ascertained, NEMO ubiquitination and NF-κB signaling is inhibited, which further emphasizes the significance of proper regulation of ubiquitination in NOD2 signaling pathways (Wertz & Dixit, 2010 .
Inflammatory bowel disease and Leśniowski-Crohn disease
IBD includes two different inflammatory conditions such as ulcerative colitis (UC) and Leśniowski-Crohn disease, often called Crohn's disease only (CD). Despite similar clinical symptoms, UC and CD are distinguished by clinical and histological features. UC is a chronic inflammation confined to the rectum or colon mucous membrane, whereas CD most commonly affects the distal part of the terminal ileum and the beginning of the colon. Inappropriate immune responses and impaired epithelial barrier functions appear to be engaged in the pathogenesis of CD. Performed studies indicate that both environmental and genetic factors contribute to its etiology. Among families affected by CD, eight loci (IBD1-IBD8) were identified, which were suspected to cause the disease (Brant & Shugart, 2004) . Through genetic and functional studies, the risk region of IBD1 has been identified and proven to be the CARD15/NOD2 gene Fernandez et al., 2004) . A considerable number of polymorphisms within the CARD15/NOD2 gene has been revealed but as so far three of them appear to be significantly associated with susceptibility to the disease. These are known as R702W (Arg702Trp), G908R (Gly908Arg), and L1007fsinsC polymorphisms. Arg702Trp and Gly908Arg mutations are single amino acid changes within the LRR domain, whereas the L1007fsinsC mutation is caused by a deletion causing reading frame shift leading to the loss of 33 amino acids (Lesage et al., 2002) . In case of homozygotes the risk of developing CD presents a 40-fold increase, whereas in case of heterozygotes only a 2-4-fold increase.
In homozygotes, the disease has proceeded asymptomatically for 10-15 years, which implies that the development of the disease is also affected by other genetic factors and environmental influences apart from CARD15 gene mutations (Eckmann et al., 2005; Carneiro et al., 2008) . There are reports indicating that type of mutation determines the location of CD and disease behavior. Therefore, L1007fs homozygotes develop the gastroduodenal involvement and also have increased risk for earlyonset of CD (Mardini et al., 2005) . CD-associated mutations result in loss of phenotype functions. showed that disease-associated mutations lead to diminished NF-κB activation upon MDP stimulation, which is consistent with the finding that mutations occur near or within the LRR NOD2 domain Hugot et al., 2001) . Furthermore, it was found that monocytes isolated from CD patients harboring the L1007fsinsC mutation produce less of pro-inflammatory cytokines such as TNF-α, IL-6, IL-8, as well as anti-inflammatory cytokine IL-10 (Netea et al., 2004; Van Heel et al., 2005) . An impaired production of IL-1β was observed in MDP-induced monocytes from a patient with NOD2 mutation Van Heel et al., 2005) . In addition, CD patients with mutant NOD2 have reduced expression of two α-defensins: α-defensin-5 and α-defensin-6 in the ileal mucosa (Wehkamp et al., 2004) . Stevens et al. (2012) NOD1 and NOD2 receptors Due to similarity between the NOD1 and NOD2 structure and signaling, appropriate tests were performed to determine whether NOD1 is associated with susceptibility to inflammatory bowel disease (IBD). The results of different research groups are contradictory. The research of Molnar et al. (2007) and McGovern et al. (2007) confirmed that relationship. However, there are reports that deny such connection . However, each of these studies concerned different populations, so it shall not be excluded that the incidence of CD depends not only on NOD1 polymorphism, but also on the population characteristics.
In turn, the studies of Travassos et al. (2010) prove the existence of functional connection between NOD1, NOD2, ATG16L1, the autophagy induction and Crohn's disease.
Blau Syndrome
Blau syndrome (BS) is a rare, inflammatory disorder inherited in an autosomal dominant pattern associated with the defect in the CARD15 gene. Blau syndrome is characterized by early-onset granulomatous dermatitis causing persistent rash and skin granulomas, granulomatous arthritis (inflammation of the synovium), and uveitis (Blau, 1985) . The NOD2 gene mutations specifically in the NBD domain such as 334Q, R334W, and L469F are known to cause Blau syndrome (Miceli-Richard et al., 2001) . NOD2 activation requires oligomerization initiated by the NBD domain, so mutations within this domain may disturb this process. These mutations also lead to the enhancement of functioning and constitutive activation of NF-κB, even in the absence of MDP stimulation Tanabe et al., 2004) . These observations gave the origin to the hypothesis that Blau syndrome is an autoimmune disease. It has not been studied yet whether mutations in the CARD15 gene have an impact on the course of Blau syndrome, and whether there is a correlation between the mutation and disease phenotype (Sfriso et al., 2012) .
Sarcoidosis
Sarcoidosis is an autoimmune disorder of unknown etiology characterized as a systemic granulomatous disease. Sarcoid granulomas are most frequently located in the lungs and the lymph nodes. This disease may affect any organ though. However, studies indicate an increased susceptibility to this disease in patients with a genetic variant of NOD1, which has a significantly reduced expression and causes impaired activation of NF-κB in response to both iEDAP and Propionibacterium acnes infection (Tanabe et al., 2006) . No correlation between NOD2 mutations and adult sarcoidosis was observed (Ho et al., 2005) .
NOD2 mutations have been shown by Kanazawa et al. (2005) to predispose to early-onset sarcoidosis (EOS). EOS differs from adult sarcoidosis aside from young age at onset, its symptoms are similar to those observed in Blau syndrome. EOS is characterized by a classic symptom triad consisting of skin, eye, and joint lesions, with pulmonary involvement on rare occasions (Cancrini et al., 1998) .
In a small study group of 10 Japanese patients diagnosed with EOS, nine had heterozygous missense mutations in the NBD domain of CARD15. In total, six different variants have been identified, five of which were identified as the new forms. Only one variant was identical to that reported in Blau syndrome. Regardless of the NOD2 variants associated with EOS, a basic activity increase of NF-κB was shown as compared with the wild type. These results correspond to those in Blau syndrome (Kanazawa et al., 2005) .
Allergic diseases
Allergies are associated with increased reactivity to antigens, IgE overproduction, and therefore are inflammatory in nature. Bacterial infection and recognition of intracellular, microbiological, products by NOD1 may constitute a cause of many cases of allergies.
It has been revealed that certain genetic NOD1 variants are associated with an increased risk of developing asthma and dermatitis atopia . The NOD1 polymorphism may modify the protective effect of early detection of allergens (Eder et al., 2006) .
The NOD1 and NOD2 receptors in the process of carcinogenesis
Reports concerning the importance of NLR in neoplasia or possible cancer prevention are very limited and mostly refer to in vitro experiments. However, a tumor-suppressor function of NOD1 has been suggested in breast cancer xenograft models by da Silva Correia et al. (2006) . Results of TLR signaling studies suggest a potential connection between NLR, and neoplasia should be considered (Rakoff-Nahoum et al., 2007; Fukata et al., 2007) . The search for a relationship between the NOD1 and NOD2 receptors activation and tumor development has begun, particularly in the gastrointestinal tract,which is rich in microorganisms. That aspect was taken into inconsideration because of the increased incidence of colorectal cancer in CD patients with 3020InsC, R702W, and G908R polymorphisms within the struc- ture of NOD2. Kurzawski and colleagues have reported as the first, a relationship between the NOD2 3020insC variant and colorectal carcinoma in Polish population (Kurzawski et al., 2004; Papaconstantinou et al., 2005) .
Polymorphisms in human NOD1 and NOD2 genes correlated with increased cancer risk. An increased risk of gastric cancer has been described in Helicobacter pylori carriers who also showed 802C-T polymorphism in NOD2, however the studies conducted on larger population have not confirmed this dependency (Hnatyszyn et al., 2010 ). An increased incidence of colon and rectum tumors was demonstrated in mouse NOD1-/-models, suggesting the importance of the NOD1 receptor in the pathogenesis of cancer (Chen et al., 2008) . However, spontaneous growth of tumors has not been observed in NOD1-deficient mice.
CONCLUSIONS
Identification of the NLR, as well as initial characterization and understanding of their functions has enabled a wider outlook on pathogen detection and eradication mechanisms as well as host immune system responses. The involvement of NLRs in the pathogenesis of several genetic diseases indicates that these proteins play an important role in the regulation of immune and inflammatory responses. Multicenter studies have enabled researchers to obtain the evidence that the NOD1 and NOD2 receptors, like other members of the NLR family, recognize conserved microbial molecules and trigger signal transduction pathways leading to the activation of kinases, caspases, and transcription factors. Regulation of gene expression under the control of NF-κB, AP1, and IRF leads in turn to stimulation of the genes responsible for the production of pro-inflammatory cytokines, chemokines, and interferons. It has been proven that NOD1 and NOD2 are involved in the process of autophagy, in the mechanism of creating the reactive oxygen species, and also in the activation of the antiviral response after NOD2 is activated by the viral ssRNA. An interaction between NLR and TLR has been demonstrated as a response against pathogens. The complete operating range of cellular mechanisms, which are responsible for regulating the activity of NOD1 and NOD2, has not been established yet. Many questions remain unanswered, including the understanding of the processes via which mutations in the NLR could be associated with the vulnerability not only to inflammation, but also cancer. This knowledge would allow for a rational therapy of diseases in general.
